Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC
Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.
Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSite revision label updated from v3.3.1 to v3.3.2. No changes to the study details, eligibility criteria, outcomes, or links on the page.SummaryDifference0.1%
- Check23 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check30 days agoChange DetectedNotice about government funding lapse and NIH operating status has been removed from the page.SummaryDifference0.4%
- Check44 days agoChange DetectedNo additions or deletions were detected; the page content remains focused on the study details and eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check73 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%
- Check80 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.